Ataxia Centre

We are a Centre of Excellence, running cutting edge, evidence based research, with biomedical and translational projects, aiming to feedback research knowledge and findings into adapted therapies and best clinical practice. In particular we work on the genetics of the ataxias, aiming to contribute to future developments in gene therapy. We also focus our research on biomarkers to support future clinical studies on ataxia. We are based at the UCL Queen Square Institute of Neurology in London. We were the first Ataxia Centre to be accredited by the patient support organisation Ataxia UK in the UK, and the only Ataxia Centre of Excellence accredited in the UK by the US based patient organisation National Ataxia Foundation.

Highlights

Research activities and updates from our team members 

First treatment for rare disease approved by UK medicines regulator

The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCL and UCLH led the UK trial – has been approved for use in the UK by the medicines’ regulator.

Professor Paola Giunti wins the EFNA Neurology Advocacy Award for Health Professional

Interview of Professor Giunti by Mrs. Ann Little, President of the EFNA

• DRPLA Natural History and Biomarkers Study - an interview with Dr Hector Garcia Moreno and Ola Volhi 
• Q&A With Dr Hector Garcia-Moreno at a support group for patients with Ataxia: part one and part two
• Update on Friedreich’s ataxia trial NICOFA by Prof Paola Giunti 
• ERN RNDs webinar by Prof Paola Giunti on the inherited ataxias